Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vaccine Company, Inc.

Clinical trials sponsored by Vaccine Company, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New mRNA vaccine targets Epstein-Barr virus in first human trial Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New mRNA vaccine targets Epstein-Barr virus in first human trial

Vaccine Not yet recruiting

This early-stage trial is testing a new mRNA vaccine called VXCO-102 against Epstein-Barr virus (EBV) in 45 healthy adults aged 18 to 25. The main goal is to check if the vaccine is safe and triggers an immune response. EBV is a common virus that can cause mononucleosis and is li…

Phase 1 • Sponsor: Vaccine Company, Inc. • Aim: Vaccine

Last updated Jun 27, 2026 12:25 UTC